Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(81 sites)
United States
Rancho Los Amigos National Rehab, Downey, California
Kansas Institute of Research, Overland Park, Kansas
Quest Research Institute, Farmington Hills, Michigan
Einstein Physical Medicine and Rehabilitation at Elkins Park, Elkins Park, Pennsylvania
The University of Texas Southwestern Medical Center, Dallas, Texas
Austria
Medical University Innsbruck, Department of Neurology, Innsbruck
Kepler University Hospital GmbH, Department of Neurology and Psychiatry, Linz
Brothers of Charity Hospital Linz, Department of Neurology I, Linz
Medical University Vienna, Department of Neurology, Vienna
Bulgaria
Multiprofile Hospital for Active Treatment "Heart and Brain", Pleven
Medical Center "Rusemed" EOOD, Rousse
Multiprofile Hospital for Active Treatment of Neurology and Psychiatry "Sveti Naum", Sofia, Neurological Diseases Clinic for Neurodegenerative and Peripheral Neurological Diseases, Sofia
Diagnostic Consulting Center - Convex EOOD, Sofia
Medical Center Medica Plus Ltd, Veliko Tarnovo
Czechia
University Hospital Hradec Kralove, Clinic of Neurology, Hradec Králové
Hospital Jihlava, Department of Neurology, Jihlava
University Hospital Ostrava, Clinic of Neurology, Center for Demyelinating diseases, Ostrava
Regional Hospital Pardubice, Clinic of Neurology, Pardubice
University Hospital Kralovske Vinohrady, Clinic of Neurology, Prague
General University Hospital in Prague, Clinic of Neurology, Prague
France
Bastia Hospital Center, Bastia
Bordeaux University Hospital Center - Pellegrin Hospital Group, Bordeaux
Brest University Hospital Center - Morvan Hospital, Brest
Raymond-Poincare Hospital - APHP, Garches
Germany
University Hospital Bonn, Clinic and Policlinic for Neurology, Bonn
Heinrich Heine University Medical Center, Department of Neurology, Düsseldorf
University Medicine Goettingen, Department of Neurology, Goettigen
University Hospital Hamburg-Eppendorf, Clinic and Polyclinic of Neurology, Hamburg
University Hospital Johannes Gutenberg - University of Mainz, Clinic and Polyclinic of Neurology, Mainz
Ludwig Maximilians University Hospital, Campus Grosshadern, Department of Neurology, Munich
GFO Clinics Troisdorf, St. Johannes Sieglar, Troisdorf
University Hospital Tuebingen, Department of Neurology, Tübingen
Hungary
Semmelweis University, Rehabilitation Clinic, Rehabilitation Department of Brain Injuries, Budapest
University of Debrecen Clinical Center, Department of Medical Rehabilitation and Physical Medicine, Debrecen
Petz Aladar University Teaching Hospital, Department of Neurology, Győr
Szent Damjan Greek Catholic Hospital, Department of Neurology and Stroke, Kisvárda
Borsod-Abauj-Zemplen County Central Hospital and University Educational Hospital, Department of Neurology, Miskolc
Italy
ASST Spedali Civili Brescia, Brescia
University Hospital "Federico II", Naples
University Polyclinic Foundation "Agostino Gemelli" - IRCCS, Rome
Clinical Research Center of Verona S.r.l. - CRC, Verona
Japan
Fukuoka Rehabilitation Hospital, Fukuoka
Chutoen General Medical Center, Department of Rehabilitation, Shizuoka
Tokushima University Hospital, Tokushima
NHO Murayama Medical Center, Department of Rehabilitation, Tokyo
Poland
St Wojciech - Adalbertus Hospital, Neurology Department, Gdansk
Specialist Doctor Practice, Katowice
Ma-Lek MS Therapy Centre, Katowice
Neuro-Medic, Katowice
Specialist Practises LLC, Krakow
Linden Medical Center, Krakow
Clinical Center for Neurology Sp. z o .o. (LLC), Krakow
NeuroKlinika - Private Practice Prof. Andrzej Bogucki, Lodz
Health Institute Dr n. med. Magdalena Boczarska-Jedynak, Oświęcim